213 related articles for article (PubMed ID: 35774143)
1. Circulating Irisin in Children and Adolescents With Prader-Willi Syndrome: Relation With Glucose Metabolism.
Mai S; Fintini D; Mele C; Convertino A; Bocchini S; Grugni G; Aimaretti G; Vietti R; Scacchi M; Crinò A; Marzullo P
Front Endocrinol (Lausanne); 2022; 13():918467. PubMed ID: 35774143
[TBL] [Abstract][Full Text] [Related]
2. Irisin levels in genetic and essential obesity: clues for a potential dual role.
Mai S; Grugni G; Mele C; Vietti R; Vigna L; Sartorio A; Aimaretti G; Scacchi M; Marzullo P
Sci Rep; 2020 Jan; 10(1):1020. PubMed ID: 31974460
[TBL] [Abstract][Full Text] [Related]
3. Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome.
Hirsch HJ; Gross I; Pollak Y; Eldar-Geva T; Gross-Tsur V
PLoS One; 2015; 10(9):e0136864. PubMed ID: 26334732
[TBL] [Abstract][Full Text] [Related]
4. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome.
Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398
[No Abstract] [Full Text] [Related]
5. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
[TBL] [Abstract][Full Text] [Related]
6. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.
Haqq AM; Muehlbauer M; Svetkey LP; Newgard CB; Purnell JQ; Grambow SC; Freemark MS
Clin Endocrinol (Oxf); 2007 Dec; 67(6):944-51. PubMed ID: 17666087
[TBL] [Abstract][Full Text] [Related]
7. The genetic background and vitamin D supplementation can affect irisin levels in Prader-Willi syndrome.
Faienza MF; Brunetti G; Grugni G; Fintini D; Convertino A; Pignataro P; Crinò A; Colucci S; Grano M
J Endocrinol Invest; 2021 Oct; 44(10):2261-2271. PubMed ID: 33656700
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome.
Mele C; Crinò A; Fintini D; Mai S; Convertino A; Bocchini S; Di Paolo P; Grugni G; Aimaretti G; Scacchi M; Marzullo P
J Endocrinol Invest; 2021 Jul; 44(7):1447-1456. PubMed ID: 33067796
[TBL] [Abstract][Full Text] [Related]
9. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.
Schuster DP; Osei K; Zipf WB
Metabolism; 1996 Dec; 45(12):1514-20. PubMed ID: 8969285
[TBL] [Abstract][Full Text] [Related]
10. Irisin and its relation to insulin resistance and puberty in obese children: a longitudinal analysis.
Reinehr T; Elfers C; Lass N; Roth CL
J Clin Endocrinol Metab; 2015 May; 100(5):2123-30. PubMed ID: 25781361
[TBL] [Abstract][Full Text] [Related]
11. The association of serum irisin with anthropometric, metabolic, and bone parameters in obese children and adolescents.
Kim SH; Kim SE; Kim S; Ahn MB; Cho WK; Cho KS; Jung MH
Front Endocrinol (Lausanne); 2023; 14():1326851. PubMed ID: 38333723
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
[TBL] [Abstract][Full Text] [Related]
13. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].
Lämmer C; Weimann E
Wien Med Wochenschr; 2007 Feb; 157(3-4):82-8. PubMed ID: 17340066
[TBL] [Abstract][Full Text] [Related]
14. Suppression of acylated ghrelin during oral glucose tolerance test is correlated with whole-body insulin sensitivity in children with Prader-Willi syndrome.
Paik KH; Choe YH; Park WH; Oh YJ; Kim AH; Chu SH; Kim SW; Kwon EK; Han SJ; Shon WY; Jin DK
J Clin Endocrinol Metab; 2006 May; 91(5):1876-81. PubMed ID: 16507634
[TBL] [Abstract][Full Text] [Related]
15. Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome.
Krochik AG; Ozuna B; Torrado M; Chertkoff L; Mazza C
J Pediatr Endocrinol Metab; 2006 Jul; 19(7):911-8. PubMed ID: 16995571
[TBL] [Abstract][Full Text] [Related]
16. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects.
Kennedy L; Bittel DC; Kibiryeva N; Kalra SP; Torto R; Butler MG
Int J Obes (Lond); 2006 Feb; 30(2):382-7. PubMed ID: 16231029
[TBL] [Abstract][Full Text] [Related]
17. Relation of serum irisin level with metabolic and antropometric parameters in obese children.
Çatlı G; Küme T; Tuhan HÜ; Anık A; Çalan ÖG; Böber E; Abacı A
J Diabetes Complications; 2016; 30(8):1560-1565. PubMed ID: 27539885
[TBL] [Abstract][Full Text] [Related]
18. Do patients with Prader-Willi syndrome have favorable glucose metabolism?
Qian Y; Xia F; Zuo Y; Zhong M; Yang L; Jiang Y; Zou C
Orphanet J Rare Dis; 2022 May; 17(1):187. PubMed ID: 35525976
[TBL] [Abstract][Full Text] [Related]
19. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents.
Jang HB; Kim HJ; Kang JH; Park SI; Park KH; Lee HJ
Metabolism; 2017 Aug; 73():100-108. PubMed ID: 28732566
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
Talebizadeh Z; Butler MG
Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
